Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.27)
# 439
Out of 5,006 analysts
92
Total ratings
38.46%
Success rate
29.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $6.41 | +87.21% | 2 | Sep 30, 2025 | |
AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.92 | +74.67% | 2 | Sep 9, 2025 | |
CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.85 | +116.22% | 10 | Sep 3, 2025 | |
NVAX Novavax | Assumes: Buy | $10 | $9.46 | +5.71% | 1 | Aug 28, 2025 | |
MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.95 | +425.76% | 6 | Aug 12, 2025 | |
KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $6.56 | +98.17% | 5 | Jul 10, 2025 | |
SENS Senseonics Holdings | Maintains: Buy | $1.1 → $1.4 | $0.46 | +202.38% | 2 | Jul 8, 2025 | |
PSTV Plus Therapeutics | Maintains: Buy | $5.5 → $3 | $0.73 | +310.28% | 12 | Jun 27, 2025 | |
CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.98 | +1.63% | 13 | May 15, 2025 | |
VSTM Verastem | Maintains: Buy | $10 → $14 | $8.70 | +60.92% | 14 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $13.96 | +43.27% | 12 | Apr 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $99.39 | -59.75% | 10 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.19 | +52.99% | 3 | Mar 26, 2025 |
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $6.41
Upside: +87.21%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.92
Upside: +74.67%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $1.85
Upside: +116.22%
Novavax
Aug 28, 2025
Assumes: Buy
Price Target: $10
Current: $9.46
Upside: +5.71%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.95
Upside: +425.76%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $6.56
Upside: +98.17%
Senseonics Holdings
Jul 8, 2025
Maintains: Buy
Price Target: $1.1 → $1.4
Current: $0.46
Upside: +202.38%
Plus Therapeutics
Jun 27, 2025
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.73
Upside: +310.28%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.98
Upside: +1.63%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $8.70
Upside: +60.92%
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $13.96
Upside: +43.27%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $99.39
Upside: -59.75%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $7.19
Upside: +52.99%